Logos Global Management LP 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-26 4:27 pm Sale | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 0 0.000% | -1,339,793 (Position Closed) | Filing |
| 2021-09-09 12:30 pm Purchase | 2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 1,339,793 9.400% | 1,339,793 (New Position) | Filing |